Research Summary Prostate cancer diagnostics encompass a range of medical procedures and tests aimed at identifying and characterizing prostate cancer. Common diagnostic tools include prostate-specific antigen (PSA) blood tests, digital rectal examinations (DRE), and imaging studies such as transrectal ultrasound (TRUS) or magnetic resonance imaging (MRI). Elevated PSA levels or abnormal findings during a DRE may prompt further investigation. Prostate biopsies, often guided by imaging techniques, involve the collection of tissue samples from the prostate for pathological examination to confirm the presence of cancer cells and determine the cancer＇s grade and extent. Advanced diagnostic methods may involve genomic testing to assess the genetic characteristics of the cancer cells. These diagnostic approaches help healthcare professionals stratify the risk, plan appropriate treatments, and monitor the progression of prostate cancer. As the field of prostate cancer diagnostics evolves, efforts focus on enhancing the accuracy of early detection, reducing unnecessary interventions, and personalizing treatment strategies based on the individual characteristics of the disease. According to DIResearch's in-depth investigation and research, the global Prostate Cancer Diagnostics market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%. The major global manufacturers of Prostate Cancer Diagnostics include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale. This report studies the market size, price trends and future development prospects of Prostate Cancer Diagnostics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Prostate Cancer Diagnostics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030. The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Prostate Cancer Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Prostate Cancer Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy. The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database. Global Key Manufacturers of Prostate Cancer Diagnostics Include: OPKO Genomic Health Abbott Beckman Coulter Siemens Healthcare bioMeriux Roche MDx Health DiaSorin Myriad Genetics Ambry Genetics Prostate Cancer Diagnostics Product Segment Include: Tumor Biomarker Tests Imaging Biopsy Other Prostate Cancer Diagnostics Product Application Include: Age Below 55 Age 55-75 Age Above 75 Chapter Scope Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends Chapter 2: Global Prostate Cancer Diagnostics Industry PESTEL Analysis Chapter 3: Global Prostate Cancer Diagnostics Industry Porter’s Five Forces Analysis Chapter 4: Global Prostate Cancer Diagnostics Major Regional Market Size and Forecast Analysis Chapter 5: Global Prostate Cancer Diagnostics Market Size and Forecast by Type and Application Analysis Chapter 6: North America Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 7: Europe Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 8: China Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 9: APAC (Excl. China) Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 10: Latin America Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 11: Middle East and Africa Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis) Chapter 12: Global Prostate Cancer Diagnostics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration) Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin) Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers Chapter 15: Research Findings and Conclusion Chapter 16: Methodology and Data Sources
Table of Contents 1 Prostate Cancer Diagnostics Market Overview 1.1 Product Definition and Statistical Scope 1.2 Prostate Cancer Diagnostics Product by Type 1.2.1 Global Prostate Cancer Diagnostics Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Tumor Biomarker Tests 1.2.3 Imaging 1.2.4 Biopsy 1.2.5 Other 1.3 Prostate Cancer Diagnostics Product by Application 1.3.1 Global Prostate Cancer Diagnostics Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Age Below 55 1.3.3 Age 55-75 1.3.4 Age Above 75 1.4 Global Prostate Cancer Diagnostics Market Revenue Analysis (2019-2030) 1.5 Prostate Cancer Diagnostics Market Development Status and Trends 1.5.1 Prostate Cancer Diagnostics Industry Development Status Analysis 1.5.2 Prostate Cancer Diagnostics Industry Development Trends Analysis 2 Prostate Cancer Diagnostics Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Prostate Cancer Diagnostics Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Prostate Cancer Diagnostics Market Analysis by Regions 4.1 Prostate Cancer Diagnostics Overall Market: 2023 VS 2024 VS 2030 4.2 Global Prostate Cancer Diagnostics Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Prostate Cancer Diagnostics Revenue and Market Share by Region (2019-2024) 4.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2025-2030) 5 Global Prostate Cancer Diagnostics Market Size by Type and Application 5.1 Global Prostate Cancer Diagnostics Market Size by Type 5.2 Global Prostate Cancer Diagnostics Market Size by Application 6 North America 6.1 North America Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Prostate Cancer Diagnostics Market Size by Type 6.4 North America Prostate Cancer Diagnostics Market Size by Application 6.5 North America Prostate Cancer Diagnostics Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Prostate Cancer Diagnostics Market Size by Type 7.4 Europe Prostate Cancer Diagnostics Market Size by Application 7.5 Europe Prostate Cancer Diagnostics Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Prostate Cancer Diagnostics Market Size by Type 8.4 China Prostate Cancer Diagnostics Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Prostate Cancer Diagnostics Market Size by Type 9.4 APAC (excl. China) Prostate Cancer Diagnostics Market Size by Application 9.5 APAC (excl. China) Prostate Cancer Diagnostics Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Prostate Cancer Diagnostics Market Size by Type 10.4 Latin America Prostate Cancer Diagnostics Market Size by Application 10.5 Latin America Prostate Cancer Diagnostics Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type 11.4 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application 11.5 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Prostate Cancer Diagnostics Market Revenue by Key Manufacturers (2020-2024) 12.2 Prostate Cancer Diagnostics Competitive Landscape Analysis and Market Dynamic 12.2.1 Prostate Cancer Diagnostics Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 OPKO 13.1.1 OPKO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 OPKO Prostate Cancer Diagnostics Product Portfolio 13.1.3 OPKO Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Genomic Health 13.2.1 Genomic Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Genomic Health Prostate Cancer Diagnostics Product Portfolio 13.2.3 Genomic Health Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Abbott 13.3.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Abbott Prostate Cancer Diagnostics Product Portfolio 13.3.3 Abbott Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Beckman Coulter 13.4.1 Beckman Coulter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Beckman Coulter Prostate Cancer Diagnostics Product Portfolio 13.4.3 Beckman Coulter Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Siemens Healthcare 13.5.1 Siemens Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio 13.5.3 Siemens Healthcare Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 bioMeriux 13.6.1 bioMeriux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 bioMeriux Prostate Cancer Diagnostics Product Portfolio 13.6.3 bioMeriux Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Roche 13.7.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Roche Prostate Cancer Diagnostics Product Portfolio 13.7.3 Roche Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 MDx Health 13.8.1 MDx Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 MDx Health Prostate Cancer Diagnostics Product Portfolio 13.8.3 MDx Health Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 DiaSorin 13.9.1 DiaSorin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 DiaSorin Prostate Cancer Diagnostics Product Portfolio 13.9.3 DiaSorin Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Myriad Genetics 13.10.1 Myriad Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Myriad Genetics Prostate Cancer Diagnostics Product Portfolio 13.10.3 Myriad Genetics Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Ambry Genetics 13.11.1 Ambry Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Ambry Genetics Prostate Cancer Diagnostics Product Portfolio 13.11.3 Ambry Genetics Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Prostate Cancer Diagnostics Industry Chain Analysis 14.2 Prostate Cancer Diagnostics Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Prostate Cancer Diagnostics Typical Downstream Customers 14.4 Prostate Cancer Diagnostics Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook